Evaluation of High Sensitive Troponin in Erectile Dysfunction

Table 1

Clinical and laboratory features of patients with erectile dysfunction. Values are reported as mean and standard deviation.

	NA-ED; ( = 40)	A-ED; ( = 48)	BL-ED; ( = 32)
Patients data
Age (years)	52.0 ± 8.5	58.1 ± 7.3	50.0 ± 10.5
IIEF-5 score	12.8 ± 2.4	10.5 ± 2.6	11.6 ± 1.8
Laboratory; evaluation
Study; parameters
hs-cTnT; (pg/mL)	2.89 ± 5.01	4.32 ± 7.29	3.10 ± 4.18
hs-cTnI; (pg/mL)	4.72 ± 10.93	2.4 ± 6.25	0.79 ± 3.88
hs-CRP; (mg/L)	1.70 ± 1.78	3.09 ± 3.19^*	2.03 ± 2.79
Other; parameters
Creatinine; (mg/dL)	0.92 ± 0.16	0.95 ± 0.16	0.96 ± 0.15
Glucose; (mg/dL)	102.9 ± 6.3	93.0 ± 14.1	95.6 ± 10.8
ALT (U/L)	26.22 ± 15.76	23.10 ± 10.29	24.46 ± 8.29
AST (U/L)	23.56 ± 10.16	21.60 ± 5.71	27.29 ± 10.28
Total; cholesterol; (mg/dL)	200.36 ± 10.21	207.80 ± 11.72	205.21 ± 9.49
HDL; cholesterol; (mg/dL)	55.14 ± 13.90	50.30 ± 10.19	52.46 ± 15.82
LDL; Cholesterol; (mg/dL)	122.56 ± 11.53	133.60 ± 10.68	128.04 ± 10.40
Triglycerides; (mg/dL)	112.97 ± 62.23	123.90 ± 58.60	125.54 ± 59.02
HbA1c (%)	5.27 ± 0.50	5.77 ± 0.52	5.56 ± 0.44
17-ß-Estradiol; (pg/mL)	27.23 ± 8.29	29.17 ± 8.61	27.45 ± 10.57
Prolactin; (ng/mL)	8.59 ± 4.66	8.64 ± 3.43	9.23 ± 3.52
Testosterone; (ng/mL)	4.97 ± 2.50	4.13 ± 1.64	4.59 ± 1.29

NA-ED: nonarteriogenic erectile dysfunction; A-ED: arteriogenic erectile dysfunction; BL-ED: borderline arteriogenic erectile dysfunction.
^* < 0.048 versus NA-ED.